Exploration of patient-derived pancreatic ductal adenocarcinoma ex vivo tissue for treatment response

HIGHLIGHTS

• who: Tu00edmea Szekerczu00e9s and collaborators from the Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, , Huddinge, Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital have published the paper: Exploration of Patient-Derived Pancreatic Ductal Adenocarcinoma Ex Vivo Tissue for Treatment Response, in the Journal: Antioxidants 2023, 12, x FOR PEER REVIEW 7 of 10 Figure 3. Effect IPA treatment the cell viability HPAF-II and PANC-1 Figure 3. Effect of IPAof treatment on the cellon viability of HPAF-II andof PANC-1 compared to control compared to control cells at different time points . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.